| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/28/2004 | EP1383787A2 Sapogenin derivatives, their synthesis and use |
| 01/28/2004 | EP1383778A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 01/28/2004 | EP1383767A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 01/28/2004 | EP1383765A1 Chemical compounds |
| 01/28/2004 | EP1383762A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 01/28/2004 | EP1383761A1 Phenyl- and pyridyl-piperidines with tnf activity |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/28/2004 | EP1383759A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 01/28/2004 | EP1383757A1 Antagonists of mcp-1 function and methods of use thereof |
| 01/28/2004 | EP1383753A1 Piperazine-benzamide derivatives useful as apob-100 and/or mtp inhibitor |
| 01/28/2004 | EP1383752A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383748A2 Novel compounds and compositions as cathepsin inhibitors |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383744A1 Novel piperidine derivatives as modulators of chemokine receptor |
| 01/28/2004 | EP1383743A2 Dual inhibitors of pde 7 and pde 4 |
| 01/28/2004 | EP1383739A1 New compounds |
| 01/28/2004 | EP1383733A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP1383551A2 Catheter and implants for the delivery of therapeutic agents to tissues |
| 01/28/2004 | EP1383526A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/28/2004 | EP1383522A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 01/28/2004 | EP1383521A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/28/2004 | EP1383520A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 01/28/2004 | EP1383505A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
| 01/28/2004 | EP1383501A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/28/2004 | EP1383489A1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/28/2004 | EP1383463A2 Pharmaceutically active compounds and methods of use |
| 01/28/2004 | EP1383447A1 Stent-based delivery of statins to prevent restenosis |
| 01/28/2004 | EP1383385A1 Use of ppar-alpha-gamma ligands or agonists to prevent the rupture of atherosclerotic plaques |
| 01/28/2004 | EP1313706A4 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 01/28/2004 | EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/28/2004 | EP1214077B1 Local delivery of 17-beta estradiol for improving vascular endothelium function after vascular injury |
| 01/28/2004 | EP1183237B1 Novel antioxidants, preparation methods and uses |
| 01/28/2004 | EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 01/28/2004 | EP1071397B1 Controlled release peroral compositions of levosimendan |
| 01/28/2004 | EP1061944B1 Therapeutic chemokine receptor antagonists |
| 01/28/2004 | EP0914345B1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/28/2004 | CN1471535A Tricyclic derivatives of indole with antiangiogenic activity |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |
| 01/28/2004 | CN1471528A Pyrrolidine derivatives and their use as chymase inhibitor |
| 01/28/2004 | CN1471527A 喹唑啉衍生物 Quinazoline derivatives |
| 01/28/2004 | CN1471523A Imidazole derivatives as Raf kinase inhibitors |
| 01/28/2004 | CN1471522A Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 01/28/2004 | CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 01/28/2004 | CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471519A Amino alkyenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471517A OXAZOLYL-arylpropionic acid derivatives and their sue as PPAR agonists |
| 01/28/2004 | CN1471515A Compounds effective as beta-2-adrenoreceptor agonists as well as PDE-4-inhibitors |
| 01/28/2004 | CN1471512A Gem-substituted ± ¢ ²3 integrin antagonists |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1471407A Multifunctional nano device platform |
| 01/28/2004 | CN1471403A Oral preparation containing seaweed for reduction of plaque and calculus |
| 01/28/2004 | CN1471402A Compositions and methods for diagnosis and treatment of cardiovascualr disorders |
| 01/28/2004 | CN1471393A Method for the treatment of neurological and neuropsychological disorders |
| 01/28/2004 | CN1471392A Method for the treatment of neurological and neuropsychological disorders |
| 01/28/2004 | CN1471390A Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction |
| 01/28/2004 | CN1470280A Rhizome alismatis capsule and pill, and its preparing method and use |
| 01/28/2004 | CN1470268A Compound Longxue scorpion and preparation method thereof |
| 01/28/2004 | CN1470265A Chinese medicinal ointment for treating piles |
| 01/28/2004 | CN1470258A Chinese medicine for treating chest paralysis |
| 01/28/2004 | CN1470255A Preparation extracted from the root of red-rooted solvia and pseudo-ginseng and its compound preparation and medical use |
| 01/28/2004 | CN1470249A Yak-blood deproteined extract and its extraction method and use thereof |
| 01/28/2004 | CN1470245A Low-molecular-weight chondroitin sulfate injecta and its preparation method |
| 01/28/2004 | CN1470241A Astragalus root methyl-glycoside composition and preparation method |
| 01/28/2004 | CN1470238A Levosimendan formulation and its preparing method |
| 01/28/2004 | CN1470236A Multicomponent preparation for treatnig piles and fissure |
| 01/28/2004 | CN1136215C Isoquinoline derivatives or salts thereof |
| 01/28/2004 | CN1136203C Benzoxazine and penzothiazine derivatives and their use in pharmaceuticals |
| 01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/28/2004 | CN1136001C Medicine for treating hypertension |
| 01/28/2004 | CN1135997C Medicine for treating cardiovascular and cerebrovascular diseases |
| 01/28/2004 | CN1135996C Chinese medicine for treating coronary heart disease and angina pectoris and its preparing process |
| 01/28/2004 | CN1135987C Use of 1-acyl-3,6-hexahydroxy dephenyl-diformacyl glucose compound in preparing medicine for anti-thrombus |
| 01/28/2004 | CN1135983C Application of diacid (5-androstene-17-one-3 beta-hydroxy) diester in preparing medicine |
| 01/28/2004 | CN1135982C Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine deriratives |
| 01/28/2004 | CN1135976C Application of cotucine in pharmacy |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683183 Bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, for treatment of proliferative disorders |
| 01/27/2004 | US6683163 Monitoring angiogenesis factor |
| 01/27/2004 | US6683158 Alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 01/27/2004 | US6683111 Such as 2-ethoxy-3-(4-(2-xanthen-9-ylidene-ethoxy)-phenyl)-propionic acid; for treating conditions associated with peroxisome proliferator-activated receptors; treatment of diabetes/obesity |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/27/2004 | US6683095 CDK inhibitors having 3-hydroxychromen-4-one structure |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683091 Heterocyclic sulfanamides; alzheimer's disease; preventing deposition of amyloid protein |
| 01/27/2004 | US6683089 N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols |
| 01/27/2004 | US6683087 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 01/27/2004 | US6683081 Triazolotriazinones and the use thereof |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683076 Methods for therapeutic use of glucosylceramide synthesis inhibitors and composition thereof |
| 01/27/2004 | US6683057 Suppressing g beta gamma signaling; reducing intimal hyper-plasia following vein grafting and restenosis following arterial injury |
| 01/27/2004 | US6683056 Synergistic mixture with antilipemic agent |
| 01/27/2004 | US6683055 Guanidine or amidine termined peptides |
| 01/27/2004 | US6683053 Insulin-like growth factor agonist molecules |
| 01/27/2004 | US6683051 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |